BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38026208)

  • 1. WIPF1 promotes gastric cancer progression by regulating PI3K/Akt signaling in a myocardin-dependent manner.
    Su F; Xiao R; Chen R; Yang T; Wang D; Xu X; Hou X; Guan Q; Feng M
    iScience; 2023 Nov; 26(11):108273. PubMed ID: 38026208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
    Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
    Hu J; Wang M; Yang Y; Xing Y; Li S
    Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
    [No Abstract]   [Full Text] [Related]  

  • 4. Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR-141-3p in gastric cancer.
    Liu Y; Lin W; Dong Y; Li X; Lin Z; Jia J; Zou W; Pan Y
    Cancer Med; 2020 Sep; 9(18):6752-6765. PubMed ID: 32725768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by
    Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ
    World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FJX1 overexpression is associated with poor prognosis and promotes gastric cancer proliferation
    Zhang H; Zhang Z; Wang Q; Wang L; Yang Z; Geng Z; Wang Y; Li J; Zuo L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):975-984. PubMed ID: 37439170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01268 promotes epithelial-mesenchymal transition, invasion and metastasis of gastric cancer
    Tang LH; Ye PC; Yao L; Luo YJ; Tan W; Xiang WP; Liu ZL; Tan L; Xiao JW
    World J Gastrointest Oncol; 2023 Aug; 15(8):1366-1383. PubMed ID: 37663944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
    Luo J; Wang H; Chen H; Gan G; Zheng Y
    Exp Physiol; 2020 Jun; 105(6):979-988. PubMed ID: 31856376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.
    Zhang T; Shen X; Liu R; Zhu G; Bishop J; Xing M
    Oncotarget; 2017 Jan; 8(1):900-914. PubMed ID: 27863429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC7A11 promotes the progression of gastric cancer and regulates ferroptosis through PI3K/AKT pathway.
    Jiang Y; Cui J; Cui M; Jing R
    Pathol Res Pract; 2023 Aug; 248():154646. PubMed ID: 37399587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
    Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
    Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
    Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
    Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric Cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
    Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway.
    Chen H; Dai G; Cai Y; Gong Q; Wu W; Gao M; Fei Z
    Cancer Cell Int; 2018; 18():97. PubMed ID: 30002604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway.
    Gao LZ; Wang JQ; Chen JL; Zhang XL; Zhang MM; Wang SL; Zhao C
    Appl Biochem Biotechnol; 2023 Nov; 195(11):6913-6926. PubMed ID: 36951936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.
    Wang L; Wen X; Luan F; Fu T; Gao C; Du H; Guo T; Han J; Huangfu L; Cheng X; Ji J
    Cancer Manag Res; 2019; 11():7877-7891. PubMed ID: 31686906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway.
    Wu X; Chen Y; Li G; Xia L; Gu R; Wen X; Ming X; Chen H
    Med Oncol; 2014 Apr; 31(4):903. PubMed ID: 24623015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.